Moreover, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analysis results further demonstrated that most of the cells remaining in the MI hearts were viable, verifying that mixed treatment with HGF-eMSCs considerably enhanced the survival and retention of BM-MSCs in failing hearts (Figure 1D). This evidence concerns the gene HGF and myocardial infarction.